Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Male Infertility - Overview
Male Infertility - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Male Infertility - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Male Infertility - Companies Involved in Therapeutics Development
Aprilbio Co Ltd
Beijing Fogangren Bio-Pharm Tech Co Ltd
Health Ever Bio-Tech Co Ltd
Igyxos SA
Park Active Molecules
Prokrea BCN SL
Reven Pharmaceuticals Inc
St George Street Capital Ltd
Male Infertility - Drug Profiles
Drug for Male Infertility - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
follicle stimulating hormone biobetter - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
FSH-01 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gene Therapy to Activate AR for Male Infertility - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MCS-5 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclol Antibody for Men and Women Infertility - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PAM-8 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pentoxifylline - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Recombint Beta Glucosidase 2 Replacement for Gaucher’s Disease and Male Infertility - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RPOT-1005a - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Activate Telomerase for Men Infertility and Women Infertility - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
trequinsin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Male Infertility - Dormant Projects
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Male Infertility, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Targets, H2 2020
Number of Products by Stage and Targets, H2 2020
Number of Products by Mechanism of Actions, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Male Infertility, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Male Infertility - Pipeline by Aprilbio Co Ltd, H2 2020
Male Infertility - Pipeline by Beijing Fogangren Bio-Pharm Tech Co Ltd, H2 2020
Male Infertility - Pipeline by Health Ever Bio-Tech Co Ltd, H2 2020
Male Infertility - Pipeline by Igyxos SA, H2 2020
Male Infertility - Pipeline by Park Active Molecules, H2 2020
Male Infertility - Pipeline by Prokrea BCN SL, H2 2020
Male Infertility - Pipeline by Reven Pharmaceuticals Inc, H2 2020
Male Infertility - Pipeline by St George Street Capital Ltd, H2 2020
Male Infertility - Dormant Projects, H2 2020